
Valeo Pharma (OTC: VPHIF) announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium
Amikacin receives Health Canada approval, commercialization to start in first half of 2021 Strong start for Ethacrynate Sodium commercialization in the U.S. Heightened commercial and scientific interest in Hesperco™ preceeds retail launch Strong fourth quarter […]